Literature DB >> 10489842

Peripheral blood cytokine responses and disease severity in respiratory syncytial virus bronchiolitis.

L Bont1, C J Heijnen, A Kavelaars, W M van Aalderen, F Brus, J T Draaisma, S M Geelen, H J van Vught, J L Kimpen.   

Abstract

The role of cellular immunity in disease severity in respiratory syncytial virus (RSV) bronchiolitis is largely unknown. This study investigated the association between disease severity and systemic cytokine responses in hospitalized ventilated and nonventilated RSV bronchiolitis patients. In whole blood cultures stimulated with phytohaemagglutinin (PHA), lymphoproliferative responses and interferon (IFN)-gamma and interleukin (IL)-4 production during acute illness were measured. In addition, plasma cytokines were measured. Measurements were repeated in the convalescent phase, 3-4 weeks after admission. Fifty patients were included. The median age in ventilaled patients was significantly lower than in nonventilated patients (1 versus 4 months, p<0.05). In comparison with nonventilated patients, the ventilated patients had significantly lower lymphoproliferative responses and a lower production of IFN-gamma and IL-4. In fact, IFN-gamma and IL-4 production in ventilated patients was almost completely undetectable. Plasma IL-8 levels in ventilated patients were significantly higher than in nonventilated patients. In the convalescent phase, lymphoproliferative and cytokine responses as well as plasma IL-8 levels were normal in both patient groups. Since RSV bronchiolitis is associated with the subsequent development of asthma, the possible skewing of the T-helper (Th1/Th2) cytokine balance was investigated. This was found neither in the acute nor in the convalescent phase. In conclusion, the data indicate that depressed lymphocyte function and elevated plasma interleukin-8 levels are markers of severe disease. It is suggested that age and maturation related immune mechanisms could explain the occurrence of severe respiratory syncytial virus bronchiolitis requiring mechanical ventilation in young infants.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10489842     DOI: 10.1034/j.1399-3003.1999.14a24.x

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  36 in total

Review 1.  Approaches to Evaluate Lung Inflammation in Translational Research.

Authors:  David K Meyerholz; Jessica C Sieren; Amanda P Beck; Heather A Flaherty
Journal:  Vet Pathol       Date:  2017-08-16       Impact factor: 2.221

2.  Concentrations of IL-15, IL-18, IFN-γ and activity of CD4+, CD8+ and NK cells at admission in children with viral bronchiolitis.

Authors:  Elżbieta Grześk; Sylwia Kołtan; Robert Dębski; Mariusz Wysocki; Marzena Gruszka; Małgorzata Kubicka; Andrzej Kołtan; Grzegorz Grześk; Sławomir Manysiak; Grażyna Odrowąż-Sypniewska
Journal:  Exp Ther Med       Date:  2010-07-20       Impact factor: 2.447

3.  Vitamin D decreases respiratory syncytial virus induction of NF-kappaB-linked chemokines and cytokines in airway epithelium while maintaining the antiviral state.

Authors:  Sif Hansdottir; Martha M Monick; Nina Lovan; Linda Powers; Alicia Gerke; Gary W Hunninghake
Journal:  J Immunol       Date:  2009-12-11       Impact factor: 5.422

4.  A systemic neutrophil response precedes robust CD8(+) T-cell activation during natural respiratory syncytial virus infection in infants.

Authors:  Michaël V Lukens; Alma C van de Pol; Frank E J Coenjaerts; Nicolaas J G Jansen; Vera M Kamp; Jan L L Kimpen; John W A Rossen; Laurien H Ulfman; Carline E A Tacke; Marco C Viveen; Leo Koenderman; Tom F W Wolfs; Grada M van Bleek
Journal:  J Virol       Date:  2009-12-16       Impact factor: 5.103

5.  Respiratory syncytial virus (RSV) RNA loads in peripheral blood correlates with disease severity in mice.

Authors:  Juan Pablo Torres; Ana M Gomez; Shama Khokhar; Vijay G Bhoj; Claudia Tagliabue; Michael L Chang; Peter A Kiener; Paula A Revell; Octavio Ramilo; Asuncion Mejias
Journal:  Respir Res       Date:  2010-09-15

6.  Decreased interferon-gamma response in respiratory syncytial virus compared to other respiratory viral infections in infants.

Authors:  J H Aberle; S W Aberle; W Rebhandl; E Pracher; M Kundi; T Popow-Kraupp
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

7.  Innate immune dysfunction is associated with enhanced disease severity in infants with severe respiratory syncytial virus bronchiolitis.

Authors:  Cesar Mella; M Carmen Suarez-Arrabal; Santiago Lopez; Julie Stephens; Soledad Fernandez; Mark W Hall; Octavio Ramilo; Asuncion Mejias
Journal:  J Infect Dis       Date:  2012-11-29       Impact factor: 5.226

8.  Severe respiratory syncytial virus infections and reduced interferon-gamma generation in vitro.

Authors:  U Schauer; S Hoffjan; T Rothoeft; H Bartz; S Konig; E Fuchs; J Bittscheidt; A Kochling; V Stephan
Journal:  Clin Exp Immunol       Date:  2004-10       Impact factor: 4.330

9.  IFN-gamma production during initial infection determines the outcome of reinfection with respiratory syncytial virus.

Authors:  Young-Mok Lee; Nobuaki Miyahara; Katsuyuki Takeda; John Prpich; Anita Oh; Annette Balhorn; Anthony Joetham; Erwin W Gelfand; Azzeddine Dakhama
Journal:  Am J Respir Crit Care Med       Date:  2007-10-25       Impact factor: 21.405

10.  Extracellular Hsp72, an endogenous DAMP, is released by virally infected airway epithelial cells and activates neutrophils via Toll-like receptor (TLR)-4.

Authors:  Derek S Wheeler; Margaret A Chase; Albert P Senft; Sue E Poynter; Hector R Wong; Kristen Page
Journal:  Respir Res       Date:  2009-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.